For the quarter ending 2025-09-30, EDIT has $201,751K in assets. $188,298K in debts. $165,648K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 165,648 | 138,542 | ||
| Marketable securities | 0 | 39,959 | ||
| Accounts receivable | 8,130 | 588 | ||
| Prepaid expenses and other current assets | 3,113 | 3,707 | ||
| Total current assets | 176,891 | 182,796 | ||
| Property and equipment, net | 4,287 | 4,576 | ||
| Right-of-use assets | 17,583 | 19,011 | ||
| Restricted cash and other non-current assets | 2,990 | 4,198 | ||
| Total assets | 201,751 | 210,581 | ||
| Accounts payable | 3,163 | 6,723 | ||
| Accrued expenses | 47,522 | 48,068 | ||
| Liability for sale of future revenues, current | 5,000 | 5,000 | ||
| Deferred revenue, current | 0 | 0 | ||
| Operating lease liabilities | 6,088 | 6,146 | ||
| Total current liabilities | 61,773 | 65,937 | ||
| Operating lease liabilities, net of current portion | 13,564 | 14,989 | ||
| Liability for sale of future revenues - non-current | 54,069 | 51,670 | ||
| Deferred revenue, net of current portion | 54,204 | 54,204 | ||
| Other non-current liabilities | 4,688 | 4,592 | ||
| Total liabilities | 188,298 | 191,392 | ||
| Common stock, 0.0001 par value per share 390,000,000 and 195,000,000 shares authorized at september30, 2025 and december31, 2024, respectively 93,264,421 and 82,734,696 shares issued and outstanding at september30, 2025 and december31, 2024, respectively | 9 | 9 | ||
| Additional paid-in capital | 1,636,327 | 1,616,931 | ||
| Accumulated other comprehensive income | 0 | 15 | ||
| Accumulated deficit | -1,622,883 | -1,597,766 | ||
| Total stockholders equity | 13,453 | 19,189 | ||
| Total liabilities and stockholders equity | 201,751 | 210,581 | ||
Editas Medicine, Inc. (EDIT)
Editas Medicine, Inc. (EDIT)